A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Purpose of Study The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

ul>

Registry of Asthma Patients Initiating DUPIXENT

The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT in a real-world setting.

The secondary objectives of the study are:

Observational Study of Adult Patients Receiving Dupixent for Atopic Dermatitis (AD)

Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020

Primary endpoint:

Estimate 1-year- and 5-year-mortality rates in patients with PLC.

Secondary endpoints:

Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis

In the same way, in many international studies, radiotherapy has been evaluating the possibility of reducing both:

Between 2004 and 2007, the CRLC [Regional Anti-Cancer Center] evaluated the feasibility and …

COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study

ul>

Because the course of the pandemic may change, the frequency of the surveys may change.

Participation lasts 2 years.

Urinary and Sexual Dysfunctions Evaluation After Rectal Resection

ul>

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage II or III colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA test results and may be recommended for adjuvant chemotherapy or …